UNLABELLED: The brainstem contains various important monoaminergic neuronal centers, including the raphe nuclei which contain serotonergic neurons. The raphe nuclei, however, are not easily identifiable and located by conventional neuroimaging. METHODS: Fluorodeoxyglucose positron emission tomography (PET) and magnetic resonance imaging (MRI) were performed in seven healthy subjects using a new PET-MRI, which consists of a high-resolution research tomograph (HRRT) PET and 7.0 T-MRI. Glucose metabolism of raphe nuclei was semiquantitatively measured and identified along the midline brainstem region in vivo. RESULTS: Midline nuclei clustered in four groups appeared to be the raphe nuclei and could be clearly visualized; specifically, we identified the groups as the dorsal raphe, raphe reticularis centralis superior, raphe pontis, and raphe magnus group. CONCLUSION: FDG imaging of the midline raphe nuclei in vivo could potentially be an important tool for investigating brain diseases as well as conducting functional brain studies in the context of sleep disorders, depression, and neurodegenerative disease.
UNLABELLED: The brainstem contains various important monoaminergic neuronal centers, including the raphe nuclei which contain serotonergic neurons. The raphe nuclei, however, are not easily identifiable and located by conventional neuroimaging. METHODS:Fluorodeoxyglucose positron emission tomography (PET) and magnetic resonance imaging (MRI) were performed in seven healthy subjects using a new PET-MRI, which consists of a high-resolution research tomograph (HRRT) PET and 7.0 T-MRI. Glucose metabolism of raphe nuclei was semiquantitatively measured and identified along the midline brainstem region in vivo. RESULTS: Midline nuclei clustered in four groups appeared to be the raphe nuclei and could be clearly visualized; specifically, we identified the groups as the dorsal raphe, raphe reticularis centralis superior, raphe pontis, and raphe magnus group. CONCLUSION: FDG imaging of the midline raphe nuclei in vivo could potentially be an important tool for investigating brain diseases as well as conducting functional brain studies in the context of sleep disorders, depression, and neurodegenerative disease.
Authors: Rajapillai L I Pillai; Mengru Zhang; Jie Yang; Maura Boldrini; J John Mann; Maria A Oquendo; Ramin V Parsey; Christine DeLorenzo Journal: Depress Anxiety Date: 2018-01-24 Impact factor: 6.505
Authors: Andreas Hahn; Daniela Haeusler; Christoph Kraus; Anna S Höflich; Georg S Kranz; Pia Baldinger; Markus Savli; Markus Mitterhauser; Wolfgang Wadsak; Georgios Karanikas; Siegfried Kasper; Rupert Lanzenberger Journal: Hum Brain Mapp Date: 2014-01-17 Impact factor: 5.038
Authors: Roberta Sclocco; Florian Beissner; Marta Bianciardi; Jonathan R Polimeni; Vitaly Napadow Journal: Neuroimage Date: 2017-02-21 Impact factor: 6.556
Authors: Markus A Dahlem; Sebastian Rode; Arne May; Naoya Fujiwara; Yoshito Hirata; Kazuyuki Aihara; Jürgen Kurths Journal: Transl Neurosci Date: 2013-09 Impact factor: 1.757
Authors: Zang Hee Cho; Young Don Son; Eun Jung Choi; Hang Keun Kim; Jeong Hee Kim; Sang Yoon Lee; Seiji Ogawa; Young Bo Kim Journal: MAGMA Date: 2012-08-03 Impact factor: 2.310
Authors: Salvatore Torrisi; Camilla L Nord; Nicholas L Balderston; Jonathan P Roiser; Christian Grillon; Monique Ernst Journal: Neuroimage Date: 2016-10-22 Impact factor: 6.556